Oniria Therapeutics

We are delighted to announce we’ve completed a seed funding round of €1,28M led by Fundación Botín with participation from BStartup of Banco Sabadell. This will allow the company to continue advancing development of #ONR001, a first-in-class drug for eliminating persistent tumour cells that remain after conventional treatment. We are so grateful to the investors, Vall d'Hebron Institute of Oncology (VHIO), Universitat de Barcelona - Fundació Bosch i Gimpera and Institució Catalana de Recerca i Estudis Avançats, ICREA for believing in Oniria Therapeutics. Press release: https://lnkd.in/ex5n4HAe 📷 Xavier Barril, Carles Galdeano, Esther Riambau, Josep Tabernero MD, PhD, Hector G Palmer and Isabel Puig Borreil, PhD, founders of Oniria Therapeutics. #cancer #CancerPersistence #PrecisionOncology #biotechnology #health

Oniria Therapeutics ha rebut un Cupó d’ACCIÓ 2024 (Generalitat de Catalunya) en la modalitat de Programes Europeus R D I. Agraïts pel suport que representa per accedir a convocatòries d'ajuts de l’European Commission. #CuponsACCIÓ #innovació

🔬 Uno de los grandes retos de la investigación en cáncer y la medicina es evitar las recaídas y la reaparición del cáncer. Por eso, en la Asociación Española Contra el Cáncer estamos apoyando, entre otras, una investigación innovadora que pretende acelerar el desarrollo de un fármaco que evite la recurrencia y recaída del cáncer. 👇 A continuación, te explicamos los detalles de esta investigación que inició hace 14 años la Dra. Isabel Puig, de la mano de la Asociación, y que seguimos apoyando. https://lnkd.in/dm6fT4yV #Investigandoencáncer #TodosContraElCáncer #WorldCancerResearchDay

An amazing week in Boston with the #Jump4Women delegation of entrepreneurs, organized by Foment del Treball Nacional and U.S. Consulate General Barcelona. We are grateful for the opportunity to present the therapeutic solutions being developed by Catalan start-ups to enhance global #health, in discussions with Mayor Michelle Wu, Segun Idowu, head of Economic Opportunity and Inclusion, and key players from the innovation ecosystem, including the MOITI Massachusetts Office of International Trade and Investment, Massachusetts Institute of Technology, Harvard University, Harvard Innovation Labs, MassChallenge, InnoVenture Labs , LabCentral, Engine Ventures, and others. Special thanks also to Tech Barcelona, LEVEL Airlines, and RCD for their support. Learn more about this trip in the media: https://lnkd.in/deZrGrNT #PrecisionOncology #CancerPersistence #biotech

💥 Oniria Therapeutics has been named one of the 10 most disruptive companies by the Government of Catalonia (ACCIÓ). For us, receiving this recognition as #CataloniaExponential Leaders reinforces our mission to have a positive impact on society through #PrecisionOncology. It is also an excellent opportunity to enjoy the benefits of being part of this community (BlindStairs | Tech-Driven Equity in Recruitment , Cuatrecasas, Magnetika, Navozyme™, Ocean Ecostructures, scentXP, Suara Cooperativa, Time is Brain, UOBO, among other startups and companies in recent years). Read press release: https://lnkd.in/dw_UtrNs 📸 #ExponentialDay24, held today at AXA Auditorium in Barcelona. #innovation

🏆 A large part of our team are biologists. It's an honor to receive the 2024 Catalan Society of Biology #Award as a start-up working to overcome #CancerPersistence. 🚶♀️We want to share it with our team, investors (Fundación Botín, BStartup of Banco Sabadell) and entities that support us in this mission (Universitat de Barcelona, Vall d'Hebron Institute of Oncology (VHIO), Institució Catalana de Recerca i Estudis Avançats, ICREA, Fundació Bosch i Gimpera, Fundación ”la Caixa”, Asociación Española contra el Cáncer, European Commission, Ministry of Science and Innovation of Spain, CDTI Innovación - Centro para el Desarrollo Tecnológico y la Innovación, ACCIÓ, AGAUR . and Foment del Treball Nacional). 📸 Yesterday at #NitBio2024 in Barcelona.    #PremisSCB2024

🏆 Today we're celebrating that Oniria Therapeutics has been selected by the newspaper L'Econòmic as one of the 10 start-ups in Catalonia with the most potential for the future: https://lnkd.in/dWDF_5_8 A pleasure to share the award with heecap, INSYLO TECHNOLOGIES, Koa Health, LuxQuanta, Mapsi Photonics, Nearby Computing, NIMBLE Diagnostics, Nuage Therapeutics and Sanno Healthcare. 📸 An iconic moment was the photo with all the entrepreneurs at CaixaForum Barcelona designed by architect Arata Isozaki. Oniria Therapeutics was represented by our CEO & Co-Founder Esther Riambau and our Co-Founder Carles Galdeano. 🖊️ Anna Pinter, Francesc Muñoz Dorado i Jordi Garriga #PrecisionOncology #CancerPersistence #cancer #biotechnology

Entre el 6 y el 8 de junio se celebró en Calatayud el III Encuentro de Jóvenes Investigadores en Cáncer (EJIC), un punto de encuentro de investigadores predoctorales de todo el territorio nacional. Muchos de los investigadores que asistieron cuentan con ayudas de Asociación Española contra el Cáncer. A lo largo de tres días los jóvenes investigadores han participado en multitud de actividades como talleres y concursos para mejorar sus habilidades transversales. El Dr. David Aguilar Recarte, PhD, Director de Biología de Oniria Therapeutics, beneficiaria de una ayuda AECC IMPACTO 2023, participó en una de las mesas redondas, compartiendo su trayectoria, alternativas profesionales fuera del ámbito académico, y su experiencia sobre la conciliación entre la vida social y científica. #InvestigandoEnCáncer #EJIC

At BIO International Convention in San Diego. Our CSO & Co-Founder Dr Hector G Palmer presenting #ONR001, a first-in-class drug designed for solid and liquid aggressive tumors unresponsive to current treatments. #BIO2024 #PrecisionOncology #CancerPersistence

🟠 Oniria Therapeutics is #hiring a JUNIOR INNOVATION MANAGER. Join our team and contribute to fight cancer: https://lnkd.in/dYUEtY3W Oniria is a biopharmaceutical company in the field of hashtag #PrecisionOncology created as spin-off of Vall d'Hebron Institute of Oncology (VHIO), Universitat de Barcelona and Institució Catalana de Recerca i Estudis Avançats, ICREA. We are located at Cellex Center, in the Vall d'Hebron campus. Vacancies funded by AGAUR's #ProgramaInvestigo 2024 (Government of Catalonia) with #NextGenerationEU funds from the European Commission. #WeAreHiring #recruiting #job #healthcare